109 related articles for article (PubMed ID: 8252943)
1. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
Schulman LL; Grossman BA; Owen J
Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
[TBL] [Abstract][Full Text] [Related]
2. Studies of beta-thromboglobulin, platelet factor 4, and fibrinopeptide A in erythrocytosis due to cyanotic congenital heart disease.
Rosove MH; Hocking WG; Harwig SS; Perloff JK
Thromb Res; 1983 Jan; 29(2):225-35. PubMed ID: 6189239
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin bonding on catheter-induced fibrin formation and platelet activation.
Nichols AB; Owen J; Grossman BA; Marcella JJ; Fleisher LN; Lee MM
Circulation; 1984 Nov; 70(5):843-50. PubMed ID: 6237807
[TBL] [Abstract][Full Text] [Related]
5. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
[TBL] [Abstract][Full Text] [Related]
6. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin.
Gallino A; Haeberli A; Hess T; Mombelli G; Straub PW
Am Heart J; 1986 Aug; 112(2):285-90. PubMed ID: 2426934
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation.
Bugiardini R; Chierchia S; Crea F; Gallino A; Wild S; Roskovec A; Lenzi S; Maseri A
Am Heart J; 1984 Aug; 108(2):255-60. PubMed ID: 6205577
[TBL] [Abstract][Full Text] [Related]
8. Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus.
Rosove MH; Frank HJ; Harwig SS
Diabetes Care; 1984; 7(2):174-9. PubMed ID: 6203689
[TBL] [Abstract][Full Text] [Related]
9. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
[TBL] [Abstract][Full Text] [Related]
10. The significance of fibrinogen derivatives in plasma in human renal failure.
Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
[TBL] [Abstract][Full Text] [Related]
11. Fibrinopeptide A, platelet factor 4, and beta-thromboglobulin levels in coronary heart disease.
Nichols AB; Owen J; Kaplan KL; Sciacca RR; Cannon PJ; Nossel HL
Blood; 1982 Sep; 60(3):650-4. PubMed ID: 6179552
[TBL] [Abstract][Full Text] [Related]
12. The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke.
Ho CH; Hu HH; Wong WJ
Thromb Res; 1989 Dec; 56(5):635-47. PubMed ID: 2534001
[TBL] [Abstract][Full Text] [Related]
13. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers.
Ito T; Tanouchi J; Kato J; Nishino M; Iwai K; Tanahashi H; Hori M; Yamada Y; Kamada T
Angiology; 1997 Oct; 48(10):901-6. PubMed ID: 9342969
[TBL] [Abstract][Full Text] [Related]
14. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
Yudelman I
Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
Kaplan KL; Nossel HL; Drillings M; Lesznik G
Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
[TBL] [Abstract][Full Text] [Related]
16. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
Eisenberg PR; Lucore C; Kaufman L; Sobel BE; Jaffe AS; Rich S
Circulation; 1990 Sep; 82(3):841-7. PubMed ID: 2394005
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
[TBL] [Abstract][Full Text] [Related]
18. [Clinical tests on the diagnosis of thrombosis].
Yamanaka M
Nihon Rinsho; 1986 May; 44(5):1076-80. PubMed ID: 2943914
[No Abstract] [Full Text] [Related]
19. Fibrinopeptide A, beta-thromboglobulin, and fibrin degradation products as screening test for the diagnosis of deep vein thrombosis.
Wojciechowski J; Olausson M; Korsan-Bengtsen K
Haemostasis; 1983; 13(4):254-61. PubMed ID: 6194049
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism.
van Hulsteijn H; Briƫt E; Koch C; Hermans J; Bertina R
Acta Med Scand; 1982; 211(5):323-30. PubMed ID: 6180602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]